Abstract
The use of angiotensin-converting enzyme (ACE) inhibitors to treat hypertension has recently increased. However, their use is associated with a persistent dry cough in a significant percentage of such patients. The present study was designed to assess the contribution of polymorphisms as a genetic marker of ACE-inhibitor-related cough in a Japanese hypertensive population. Genotyping was carried out in 190 patients, 70 with cough and 120 without cough, who had been treated with ACE inhibitors. Polymorphisms of ACE insertion/deletion (I/D), angiotensin II type 1 receptor (1166A/C), type 2 receptor (3123C/A), and bradykinin B2 receptor (−58T/C, exon 1, I/D), were analyzed in these subjects. The TT genotype and T allele of bradykinin B2 receptor (−58T/C) were identified at a significantly higher frequency in the cough (+) patients than in the cough (−) patients. This difference was even more pronounced in women. However, there was no significant relationship between polymorphisms of ACE, angiotensin II receptors, or bradykinin B2 receptor exon 1, and occurrence of ACE-inhibitor-related cough. The transcriptional activity of the bradykinin B2 receptor promoter is involved in the occurrence of cough, and this new marker may provide a valuable tool to detect patients at risk of developing this side effect of ACE inhibitors. In conclusion, Susceptibility to develop cough is associated with a genetic variant of the bradykinin B2 receptor promoter; thus, it may be possible to identify those patients who will develop this adverse reaction to ACE inhibitors in advance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Vaughan DE, Pfeffer MA . Angiotensin converting enzyme inhibitors and cardiovascular remodeling Cardiovasc Res 1994 28: 159–165
St. John Sutton M et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction Circulation 1994 89: 68–75
Garg R, Yusuf S . Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials JAMA 1995 273: 1450–1456
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 1991 325: 293–302
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 1993 342: 812–828
The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 1987 316: 1429–1435
Pfeffer MA et al. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators N Engl J Med 1992 327: 669–677
Andrejak M, Andrejak MT, Osterman G . Enalapril, captopril, and cough Arch Intern Med 1988 148: 249
Karpman I . Cough from ACE inhibitors Am Heart J 1988 116: 1658
McEwan JR, Choudry N, Street R, Fuller RW . Change in cough reflex after treatment with enalapril and ramipril Br Med J 1989 299: 13–16
Furuya K et al. Angiotensin-I-converting enzyme polymorphism and susceptibility to cough Lancet 1994 343: 354
Zee RYL et al. Three candidate genes and angiotensin-converting enzyme inhibitor-related cough Hyper-tension 1998 31: 925–928
Mukae S et al. Bradykinin B2 receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough Hypertension 2000 36: 127–131
Braun A et al. Polymorphism in the gene for the human β2-bradykinin receptor. New tools assessing a genetic risk for bradykinin-associated diseases Immuno-pharmacology 1996 33: 32–35
Rigat B et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 1990 86: 1343–1346
Doria A, Warram JH, Krolewski AS . Dde I polymorphism in the AT1R gene Hum Mol Genet 1994 3: 1444
Takami S et al. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension Am J hypertens 1998 11: 316–321
Katsuya T, Horiuchi M, Minami S . Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome Mol Cell Endocrinol 1997 127: 221–228
Kammerer S, Braun A, Arnold N, Roscher AA . The human bradykinin β2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region Biochem Biophys Res Commun 1995 211: 226–233
Os I et al. Cough associated with lisinopril-treatment is sex-dependent [abstract p. 102] J Hypertens 1992 10: (Suppl 4) S135
Stoller JK, Elghazawi A, Metha A, Vidt DG . Captopril-induced cough Chest 1988 93: 659–661
Regoli D, Rhaleb NE, Drapeau G, Dion S . Kinin receptor subtypes J Cardiovasc Pharmacol 1990 15: (Suppl 6) 30–38
Burch RM, Kyle DJ . Mini review. Recent development in the understanding of bradykinin receptors Life Sci 1992 50: 829–838
Eggerickx D et al. Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene Biochem Biophys Res Commun 1992 187: 1306–1313
Hess JF et al. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor Biochem Biophys Res Commun 1992 184: 260–268
Powell SJ et al. Human bradykinin B2 receptor: nucleotide sequence analysis and assignment to chromosome 14 Genomics 1993 15: 435–438
Ma JX, Wang DZ, Chao L, Chao J . Cloning, sequence analysis and expression of the gene encoding the mouse bradykinin B2 receptor Gene 1994 149: 283–288
Ma JX et al. Structure and chromosomal localisation of the gene (BDKRB2) encoding human bradykinin B2 receptor Genomics 1994 23: 362–369
Pesquero JB et al. Molecular structure and expression of bradykinin B2 receptor gene J Biol Chem 1994 269: 26 920–26 925
Mukae S et al. Promoter polymorphism of the B2 bradykinin receptor gene is associated with essential hypertension J Circ J 1999 63: 759–762
Gainer JV et al. Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans Am J Hypertens 2000 13: 1268–1273
Okumura H et al. No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients Yakugaku Zassshi 2001 121: 253–257
Tiret L et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction Lancet 1993 341: 991–992
Bonnardeaux A et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension Hypertension 1994 24: 63–69
Jalowy A et al. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs J Am Coll Cardiol 1998 32: 1787–1796
Tsutsumi Y et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibrobasts are the major cell type for its expression Circ Res 1998 83: 1035–1046
Kuizinga MC, Smits JFM, Arends JW, Daemen MJAP . AT2- receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction J Mol Cell Cardial 1998 30: 425–434
Lee YJ, Tsai JCR . Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor −58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus Metabolism 2001 50: 1346–1350
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mukae, S., Itoh, S., Aoki, S. et al. Association of polymorphisms of the renin–angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough. J Hum Hypertens 16, 857–863 (2002). https://doi.org/10.1038/sj.jhh.1001486
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001486
Keywords
This article is cited by
-
Interactions between diabetic and hypertensive drugs: a pharmacogenetics approach
Molecular Genetics and Genomics (2023)
-
Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity
American Journal of Cardiovascular Drugs (2016)
-
A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough
The Pharmacogenomics Journal (2016)
-
An update on the pharmacogenetics of treating hypertension
Journal of Human Hypertension (2015)
-
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril
European Journal of Clinical Pharmacology (2013)